Cellular and Humoral Immune Responses to Pandemic Influenza Vaccine in Healthy and in Highly Active Antiretroviral Therapy-Treated HIV Patients

Influenza vaccination is recommended for HAART-treated HIV patients to prevent influenza illness and complications. Due to the known ability of T cells to mediate a broadly cross-reactive response, vaccination effectiveness in cell-mediated immune (CMI) response induction is a main objective in new...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Agrati, Chiara, Gioia, Cristiana, Castilletti, Concetta, Lapa, Daniele, Berno, Giulia, Puro, Vincenzo, Carletti, Fabrizio, Cimini, Eleonora, Nisii, Carla, Castellino, Flora, Martini, Federico, Capobianchi, Maria R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2012
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3505053/
https://ncbi.nlm.nih.gov/pubmed/22439734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2011.0371
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi